ISRCTN70158709已完成未知
Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria and recurring renal calcium lithiasis: an observational study
San Cecilio University Hospital (Spain)0 个研究点目标入组 70 人开始时间: 2012年5月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Men and women 25-60 years of age with moderate or severe lithiasic disease and bone mineral density loss
排除标准
- •1. Patients> 60 or <25 years
- •2. Patients with congenital bone disease
- •3. Congenital renal disease
- •4. Hyperparathyroidism
- •5. Inflammatory bowel disease or renal tubular acidosis and
- •6. Patients undergoing hormone replacement therapy or treatment with corticosteroids, calcium and/or vitamin D
研究者
相似试验
已完成
2 期
Comparison of the effect of Bisphosphonate on the prevention of type 2 diabetes among Osteopenic menopause prediabetes women and Referred to Isfahan Endocrine and Metabolism Research Center.Prediabetes.Impaired glucose tolerance, Menopausal and other perimenopausal disorders, Postmenopausal osteoporosisR73, N95,IRCT2016101530309N1Vice chancellor for research, Isfahan University of Medical Sciences60
进行中（未招募）
不适用
Effect of aminobisphosphonates and statins on circulating Vy9Vd2-T cellspatients with malignant bone metastasesMedDRA version: 12.1Level: LLTClassification code 10005993Term: Bone metastasesEUCTR2010-018491-24-NLVrije Universiteit Medical Center
已完成
不适用
Effect of aminobisphosphonates and statins on circulating Vgamma9Vdelta2-T cellscancertumor10027476NL-OMON36478Vrije Universiteit Medisch Centrum40
进行中（未招募）
不适用
Effects of drug treatment with bisphosphonates (zoledronic acid) in the prevention of skeletal events in breast cancer patients with osteoporosis. Significant correlation with some biological parameters - NDMedDRA version: 12.1Level: LLTClassification code 10057654Term: Breast cancer femaleBreast cancerEUCTR2010-019216-20-ITAZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI
已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuriaISRCTN12672997niversity Medical Centre Utrecht (UMCU) (The Netherlands)6